The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant targeted therapy in early resectable HER2-mutant lobular breast cancer.
 
Laura Carpin Kennedy
Consulting or Advisory Role - Daiichi Sankyo/Astra Zeneca
Research Funding - Puma Biotechnology (Inst); Roche/Genentech (Inst)
 
Nisha Unni
Honoraria - M3
Consulting or Advisory Role - bioTheranostics; Pfizer
 
Ariella Hanker
Research Funding - Lilly
 
Carlos L. Arteaga
Stock and Other Ownership Interests - Provista Diagnostics
Consulting or Advisory Role - Arvinas; Astrazeneca; Athenex; Daiichi Sankyo; Immunomedics; Lilly; Merck; Novartis; Origimed; Puma Biotechnology; Sanofi; Taiho Pharmaceutical
Research Funding - Lilly; Pfizer
Other Relationship - Susan G. Komen for the Cure
(OPTIONAL) Uncompensated Relationships - Susan G. Komen for the Cure